Metropolitan Life Insurance CO Celldex Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $18,948 - $27,911	538 Added 19.7%	3,269 $137,000
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $4,784 - $7,042	188 Added 7.39%	2,731 $75,000
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $10,086 - $13,754	-290 Reduced 10.24%	2,543 $91,000
Q4 2022 Jun 14, 2023	BUY	$27.78 - $45.38 $8,056 - $13,160	290 Added 11.4%	2,833 $126 Million
Q4 2022 Mar 30, 2023	SELL	$27.78 - $45.38 $4,528 - $7,396	-163 Reduced 5.44%	2,833 $126,000
Q4 2022 Feb 15, 2023	SELL	$27.78 - $45.38 $4,528 - $7,396	-163 Reduced 5.44%	2,833 $126,000
Q3 2022 Jun 14, 2023	BUY	$22.7 - $37.57 $10,283 - $17,019	453 Added 17.81%	2,996 $84.2 Million
Q2 2022 Jun 20, 2023	BUY	$20.5 - $37.33 $9,286 - $16,910	453 Added 17.81%	2,996 $80,000
Q1 2022 Jun 20, 2023	BUY	$27.64 - $39.32 $12,520 - $17,811	453 Added 17.81%	2,996 $102,000
Q1 2022 Mar 30, 2023	SELL	$27.64 - $39.32 $252,961 - $359,856	-9,152 Reduced 75.34%	2,996 $102,000
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $252,961 - $359,856	-9,152 Reduced 75.34%	2,996 $102,000
Q4 2021 Jun 21, 2023	BUY	$35.68 - $56.27 $342,706 - $540,473	9,605 Added 377.7%	12,148 $469,000
Q3 2021 Jun 21, 2023	BUY	$28.95 - $55.99 $278,064 - $537,783	9,605 Added 377.7%	12,148 $655,000
Q3 2021 Mar 30, 2023	BUY	$28.95 - $55.99 $30,136 - $58,285	1,041 Added 9.37%	12,148 $655,000
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $30,136 - $58,285	1,041 Added 9.37%	12,148 $656,000
Q2 2021 Jun 21, 2023	BUY	$20.71 - $35.37 $177,360 - $302,908	8,564 Added 336.77%	11,107 $371,000
Q2 2021 Mar 30, 2023	BUY	$20.71 - $35.37 $171,354 - $292,651	8,274 Added 292.06%	11,107 $371,000
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $230,025 - $392,854	11,107 New	11,107 $371,000

Others Institutions Holding CLDX

# of Institutions

203

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

Wellington Management Group LLP Boston, MA

9.24M
Shares

$220 Million
0.06% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$112 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.87M
Shares

$92 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.46M
Shares

$82.2 Million
9.64% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$79.2 Million
1.99% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account